Results 181 to 190 of about 380,997 (339)

Life after radical cystectomy: A mixed-methods targeted review of patient-reported quality of life following bladder removal. [PDF]

BJUI Compass
Griebsch I, Juul K, Bottomley A, Sherafat-Kazemzadeh R, Pemment J, Brooks T, Adiutori R, Bothorel S.   +7 more
europepmc   +1 more source

GLP‐1RA use improves outcomes post partial nephrectomy in T2DM patients with RCC: A TriNetX study

BJUI Compass, Volume 7, Issue 2, February 2026.
Abstract Objectives The purpose of this study is to investigate the impact of Glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) use on 90‐day postoperative outcomes and overall survival following partial nephrectomy (PN) for renal cell carcinoma (RCC), where type 2 diabetes mellitus (T2DM) is a common comorbidity.
Sam Kwon, Fiona Wardrop, Diego Gonzalez, Francis Ryan, Liza Khutsishvili, Rollins Turner, Mohammad Ghassab Deameh, Michael J. Whalen   +7 more
wiley   +1 more source

Systematic druggable genome-wide analysis to identify potential therapeutic targets for urologic diseases. [PDF]

Genes Dis
Shi Y, Chen H, Zhang X, Yin C, Lian P.
europepmc   +1 more source

Remote delivery of cancer genetic testing in veterans with metastatic prostate cancer: A Million Veteran Program pilot study

Cancer, Volume 132, Issue 3, 1 February 2026.
Abstract Background Germline pathogenic variants can inform targeted therapy for metastatic prostate cancer (mPC), and improve cancer early detection and risk reduction for family members. Guidelines recommend germline genetic testing be offered to all men with mPC, yet uptake of testing is only 10%–12%. Methods This prospective study enrolled veterans
Bruce Montgomery, Julie A. Lynch, Jessica Brown, Kara N. Maxwell, Craig C. Teerlink, Nismeta Kabilovic, Katie Stoll, Julie Simon, Maria Kogan, Sajida Hassan, Stacey B. Whitbourne, Sumitra Muralidhar, Martin W. Schoen, Rachel Ramoni, J. Michael Gaziano, Alexandra O. Sokolova, Heather H. Cheng, Ruth Etzioni, Colin C. Pritchard   +18 more
wiley   +1 more source

Lower extremity lymphedema after pelvic nodal dissection for urologic cancers is associated with metastatic recurrence. [PDF]

Can Urol Assoc J
Pogson K, Carpinito GP, Mijares-Diaz F, Mangat SA, Khan K, Bjurlin MA, Ogunleye A.   +6 more
europepmc   +1 more source

The Dublin International Society of Urological Pathology (ISUP) Consensus Conference on Best Practice Recommendations on the Pathology of Urachal Neoplasms

Henning Reis, Hikmat Al‐Ahmadie, Nadine T. Gaisa, Antonio López-Beltrán, Fiona Maclean, Toyonori Tsuzuki, Isabela W. Cunha, Mahul B. Amin, Jonathan Aning, Manju Aron, Daniel Abensur Athanazio, Richard Bambury, Liang Cheng, Anuradha Gopalan, Christian Gulmann, Charles C. Guo, Carole A. Harris, Gopa Iyer, Rafael E. Jiménez, Masahiro Jinzaki, Eiji Kikuchi, Priti Lal, Kosuke Miyai, George J. Netto, Chin-Chen Pan, Valeria Panebianco, Bas W. van Rhijn, Arlene O. Siefker‐Radtke, Steven C. Smith, Tibor Szarvas, Sara E. Wobker, Glen Kristiansen, Gladell P. Paner, the ISUP Expert Panel on Urachal Neoplasms and Urinary Bladder Glandular Lesions   +33 more
openalex   +1 more source

The Physiology of Lived Experience: And then there was one – the story of a radical nephrectomy

Experimental Physiology, EarlyView.
Michael J. Shattock
wiley   +1 more source

Hypofractionated Radiation Therapy for Pain Relief of Patients With Spinal Metastasis: A Real‐World Analysis

Cancer Reports, Volume 9, Issue 2, February 2026.
ABSTRACT Purpose Spinal metastases may cause pain, neurological compromise, paraplegia, and limb movement disorders; their management requires a comprehensive approach. Alongside systemic anti‐tumor therapies, focal interventions such as radiotherapy, bone‐modifying agents, and surgery are crucial for slowing disease progression and managing pain in ...
Lu Sun, Fan Luo, Yajuan Zhou, Xiyou Liu, Pingping Zhang, Dan Li, Yi Peng   +6 more
wiley   +1 more source

Comprehensive molecular profiling of urologic tumors presented in a molecular tumor board: insights from a real-world precision oncology cohort. [PDF]

Front Oncol
Glienke M, Himmelsbach R, Zirngibl M, Metzger P, Kühn J, Miething C, Sigle A, Gratzke C, Nientiedt C, Rassner M, Becker H, Duyster J, Lassmann S, Werner M, Börries M, Grabbert M.   +15 more
europepmc   +1 more source

Anticancer Molecular Mechanisms of Curcuminoids: An Updated Review of Clinical Trials

Food Science &Nutrition, Volume 14, Issue 2, February 2026.
Curcuminoids remain one of the most studied dietary polyphenols as a cancer prevention and treatment agent. Inflammation and tumor progression are related to the NF‐κB signaling pathway, which is also suppressed by curcuminoids. Curcuminoids prevent the activation of a variety of signaling pathways, including the MAPK, PI3K/Akt, and NF‐kB pathways ...
Ushna Momal, Muhammad Shahbaz, Asfa Perween, Muhammad Hammad ul Hassan, Hammad Naeem, Zubda Shahid, Muzzamal Hussain, Muhammad Imran, Suliman A. Alsagaby, Waleed Al Abdulmonem, Mohamed A. Abdelgawad, Mohammed M. Ghoneim, Tadesse FentaYehuala, Samy Selim, Ehab M. Mostafa   +14 more
wiley   +1 more source